FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.
marketwatch.com
23.09.2026 14:39
47 views
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.
Related stories
UK and EU agree draft deal to scrap Brexit red tape over food exports
bbc.co.uk · 03.11
Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter
marketwatch.com · 03.11
Apple’s iPhone business is booming. Here’s why the stock is falling anyway.
marketwatch.com · 03.11
From scooters to shampoo - the people saving hundreds from dumpster diving
bbc.co.uk · 03.11
US to hold first talks with Russia and Ukraine since February
ft.com · 03.11
US to hold first talks with Russia and Ukraine since February
ft.com · 03.11